| 08/14/2026 9:38 AM | PRICE T ROWE ASSOCIATES INC /MD/ (80255) Filed by Quest Diagnostics (1022079) Subject | Form SCHEDULE 13G/A | |
| 07/02/2026 3:34 PM | Quest Diagnostics (1022079) Issuer WENTWORTH TIMOTHY C (1252016) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 06/08/2026 3:32 PM | KUPPUSAMY KARTHIK (1955217) Reporting Quest Diagnostics (1022079) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 06/04/2026 1:52 PM | KUPPUSAMY KARTHIK (1955217) Reporting Quest Diagnostics (1022079) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 06/02/2026 5:38 PM | Davis J. E. (1599837) Reporting Quest Diagnostics (1022079) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 06/01/2026 11:26 AM | Davis J. E. (1599837) Reporting Quest Diagnostics (1022079) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 05/21/2026 3:48 PM | Quest Diagnostics (1022079) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 05/21/2026 3:52 PM | PFEIFFER GARY M (1127304) Reporting Quest Diagnostics (1022079) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 05/08/2026 3:15 PM | Quest Diagnostics (1022079) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 05/01/2026 3:15 PM | Quest Diagnostics (1022079) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 04/30/2026 12:08 PM | Quest Diagnostics (1022079) Subject VANGUARD CAPITAL MANAGEMENT LLC (2100119) Filed by | Form SCHEDULE 13G | |
Get the Latest News and Ratings for DGX and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Quest Diagnostics and its competitors with MarketBeat's FREE daily newsletter.
|
| 04/29/2026 1:39 PM | Quest Diagnostics (1022079) Subject VANGUARD PORTFOLIO MANAGEMENT LLC (2100121) Filed by | Form SCHEDULE 13G | |
| 04/28/2026 4:22 PM | Quest Diagnostics (1022079) Filer | Form 424B2 Transaction specifc information for a delayed shelf offering | |
| 04/27/2026 3:17 PM | Quest Diagnostics (1022079) Subject | Form FWP | |
| 04/27/2026 7:47 AM | Quest Diagnostics (1022079) Filer | Form 424B2 Transaction specifc information for a delayed shelf offering | |
| 04/24/2026 5:23 PM | DELANEY MARK E (1955265) Reporting Quest Diagnostics (1022079) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 04/24/2026 5:23 PM | KUPPUSAMY KARTHIK (1955217) Reporting Quest Diagnostics (1022079) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 04/24/2026 5:23 PM | Lassiter Wright III (1805909) Reporting Quest Diagnostics (1022079) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 04/24/2026 5:23 PM | CARTER ROBERT B (1197607) Reporting Quest Diagnostics (1022079) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 04/24/2026 5:24 PM | Gregg Vicky B (1510304) Reporting Quest Diagnostics (1022079) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 04/24/2026 5:24 PM | Plewman Patrick (1497368) Reporting Quest Diagnostics (1022079) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 04/24/2026 5:24 PM | Quest Diagnostics (1022079) Issuer SAMAD SAM (1694295) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 04/22/2026 3:12 PM | Quest Diagnostics (1022079) Filer | Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
| 04/21/2026 5:48 AM | Quest Diagnostics (1022079) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 04/06/2026 3:32 PM | Quest Diagnostics (1022079) Filer | Form DEF 14A | |
| 04/06/2026 3:33 PM | Quest Diagnostics (1022079) Filer | Form DEFA14A | |
| 04/02/2026 4:16 PM | Quest Diagnostics (1022079) Issuer WENTWORTH TIMOTHY C (1252016) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 03/27/2026 10:36 AM | Quest Diagnostics (1022079) Subject VANGUARD GROUP INC (102909) Filed by | Form SCHEDULE 13G/A | |
| 03/11/2026 5:03 PM | Quest Diagnostics (1022079) Issuer WENTWORTH TIMOTHY C (1252016) Reporting | Form 3 Initial statement of beneficial ownership of securities | |
| 03/11/2026 5:05 PM | Quest Diagnostics (1022079) Issuer WENTWORTH TIMOTHY C (1252016) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 03/06/2026 3:44 PM | Plewman Patrick (1497368) Reporting Quest Diagnostics (1022079) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 03/06/2026 3:44 PM | Davis J. E. (1599837) Reporting Quest Diagnostics (1022079) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 03/06/2026 3:44 PM | PREVOZNIK MICHAEL E (1222679) Reporting Quest Diagnostics (1022079) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 03/06/2026 3:44 PM | DELANEY MARK E (1955265) Reporting Quest Diagnostics (1022079) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 03/06/2026 3:45 PM | Doherty Catherine T. (1520897) Reporting Quest Diagnostics (1022079) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 03/06/2026 3:45 PM | Quest Diagnostics (1022079) Issuer SAMAD SAM (1694295) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 03/06/2026 3:43 PM | Deppe Michael J (1771759) Reporting Quest Diagnostics (1022079) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 03/06/2026 3:43 PM | KUPPUSAMY KARTHIK (1955217) Reporting Quest Diagnostics (1022079) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 03/05/2026 10:53 AM | PREVOZNIK MICHAEL E (1222679) Reporting Quest Diagnostics (1022079) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 03/05/2026 9:55 AM | Doherty Catherine T. (1520897) Reporting Quest Diagnostics (1022079) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 03/05/2026 9:43 AM | Plewman Patrick (1497368) Reporting Quest Diagnostics (1022079) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
Why major institutions are piling into this digital asset now (Ad) BlackRock, JPMorgan, Goldman Sachs, and Fidelity are reportedly accumulating a scarce blockchain asset - one that gets burned with every transaction on what analysts are calling America's new financial grid.
The Nasdaq has received SEC approval to move stocks onto blockchain rails, and BlackRock CEO Larry Fink dedicated his entire 2026 annual letter to this infrastructure shift. Blockchain analyst Andy Howard is calling this asset 'Digital Oil' - and says institutional buyers are already positioned. Get the name, the ticker, and exactly how to buy it |
| 03/04/2026 3:37 PM | Deppe Michael J (1771759) Reporting Quest Diagnostics (1022079) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 03/04/2026 3:37 PM | DELANEY MARK E (1955265) Reporting Quest Diagnostics (1022079) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 03/04/2026 3:37 PM | KUPPUSAMY KARTHIK (1955217) Reporting Quest Diagnostics (1022079) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 03/04/2026 3:38 PM | Plewman Patrick (1497368) Reporting Quest Diagnostics (1022079) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 03/04/2026 3:38 PM | Davis J. E. (1599837) Reporting Quest Diagnostics (1022079) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 03/04/2026 3:38 PM | PREVOZNIK MICHAEL E (1222679) Reporting Quest Diagnostics (1022079) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 03/04/2026 3:39 PM | Quest Diagnostics (1022079) Issuer SAMAD SAM (1694295) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 03/04/2026 3:39 PM | Doherty Catherine T. (1520897) Reporting Quest Diagnostics (1022079) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 03/03/2026 11:53 AM | Doherty Catherine T. (1520897) Reporting Quest Diagnostics (1022079) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 03/03/2026 11:12 AM | PREVOZNIK MICHAEL E (1222679) Reporting Quest Diagnostics (1022079) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 03/03/2026 10:52 AM | Plewman Patrick (1497368) Reporting Quest Diagnostics (1022079) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 03/02/2026 1:21 PM | Davis J. E. (1599837) Reporting Quest Diagnostics (1022079) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 02/20/2026 4:06 PM | Gregg Vicky B (1510304) Reporting Quest Diagnostics (1022079) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 02/20/2026 4:07 PM | CARTER ROBERT B (1197607) Reporting Quest Diagnostics (1022079) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 02/20/2026 4:08 PM | Lassiter Wright III (1805909) Reporting Quest Diagnostics (1022079) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 02/20/2026 4:09 PM | Deppe Michael J (1771759) Reporting Quest Diagnostics (1022079) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 02/20/2026 4:10 PM | DELANEY MARK E (1955265) Reporting Quest Diagnostics (1022079) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 02/20/2026 4:10 PM | KUPPUSAMY KARTHIK (1955217) Reporting Quest Diagnostics (1022079) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 02/20/2026 4:11 PM | Doherty Catherine T. (1520897) Reporting Quest Diagnostics (1022079) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 02/20/2026 4:11 PM | Davis J. E. (1599837) Reporting Quest Diagnostics (1022079) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 02/20/2026 4:12 PM | PREVOZNIK MICHAEL E (1222679) Reporting Quest Diagnostics (1022079) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 02/20/2026 4:12 PM | Quest Diagnostics (1022079) Issuer SAMAD SAM (1694295) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 02/20/2026 4:13 PM | Plewman Patrick (1497368) Reporting Quest Diagnostics (1022079) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 02/19/2026 9:34 AM | Plewman Patrick (1497368) Reporting Quest Diagnostics (1022079) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 02/19/2026 9:19 AM | PREVOZNIK MICHAEL E (1222679) Reporting Quest Diagnostics (1022079) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 02/19/2026 9:23 AM | Doherty Catherine T. (1520897) Reporting Quest Diagnostics (1022079) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 02/10/2026 11:46 AM | Plewman Patrick (1497368) Reporting Quest Diagnostics (1022079) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 02/10/2026 5:53 AM | Quest Diagnostics (1022079) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 01/12/2026 3:37 PM | Quest Diagnostics (1022079) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 11/28/2025 3:30 PM | Gregg Vicky B (1510304) Reporting Quest Diagnostics (1022079) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 11/28/2025 3:30 PM | Davis J. E. (1599837) Reporting Quest Diagnostics (1022079) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 11/25/2025 3:24 PM | Davis J. E. (1599837) Reporting Quest Diagnostics (1022079) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 11/25/2025 8:42 AM | Gregg Vicky B (1510304) Reporting Quest Diagnostics (1022079) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 11/18/2025 10:02 AM | DELANEY MARK E (1955265) Reporting Quest Diagnostics (1022079) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 11/07/2025 3:29 PM | Davis J. E. (1599837) Reporting Quest Diagnostics (1022079) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 10/24/2025 5:11 PM | Quest Diagnostics (1022079) Issuer SAMAD SAM (1694295) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 10/24/2025 5:09 PM | CARTER ROBERT B (1197607) Reporting Quest Diagnostics (1022079) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 10/24/2025 5:09 PM | DELANEY MARK E (1955265) Reporting Quest Diagnostics (1022079) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 10/24/2025 5:10 PM | Gregg Vicky B (1510304) Reporting Quest Diagnostics (1022079) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 10/24/2025 5:10 PM | PFEIFFER GARY M (1127304) Reporting Quest Diagnostics (1022079) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 10/24/2025 5:11 PM | KUPPUSAMY KARTHIK (1955217) Reporting Quest Diagnostics (1022079) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 10/24/2025 5:11 PM | Plewman Patrick (1497368) Reporting Quest Diagnostics (1022079) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 10/22/2025 1:10 PM | PFEIFFER GARY M (1127304) Reporting Quest Diagnostics (1022079) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 10/21/2025 5:50 AM | Quest Diagnostics (1022079) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 10/21/2025 5:31 AM | Quest Diagnostics (1022079) Filer | Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
| 09/30/2025 3:36 PM | PREVOZNIK MICHAEL E (1222679) Reporting Quest Diagnostics (1022079) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 09/26/2025 3:12 PM | PREVOZNIK MICHAEL E (1222679) Reporting Quest Diagnostics (1022079) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 09/25/2025 3:39 PM | PREVOZNIK MICHAEL E (1222679) Reporting Quest Diagnostics (1022079) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 09/24/2025 3:10 PM | PREVOZNIK MICHAEL E (1222679) Reporting Quest Diagnostics (1022079) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 09/23/2025 3:14 PM | PREVOZNIK MICHAEL E (1222679) Reporting Quest Diagnostics (1022079) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
The part that convinced me Joel is legit (Ad) Joel Peterson publishes his trade plans on a public record, a rare move for anyone claiming an edge in trading. His system shows a verifiable 74-78% win rate, checkable before you ever pay a dollar.
His free workshop breaks down the TCC Sentinel engine, the Cycle Pro Dashboard for entries and exits, and WaveBot Automation that runs plans around the clock. Save your free seat to see the verified win rate now |
| 08/25/2025 3:27 PM | Plewman Patrick (1497368) Reporting Quest Diagnostics (1022079) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 08/21/2025 3:34 PM | Plewman Patrick (1497368) Reporting Quest Diagnostics (1022079) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 08/21/2025 11:10 AM | Plewman Patrick (1497368) Reporting Quest Diagnostics (1022079) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |